Bayes Investments

We are advisors to the Made in Italy Fund, a mutual fund exclusively focused on Italian small capitalization stocks.

THE FUND

The Italian stock market is concentrated in financial companies and public utilities. Add ENI in Energy and a few Consumer stocks and you have three quarters of the market. As a result, an investor who buys an Italy ETF, or an “Italian equity” fund benchmarked around the index, is buying those few sectors and therefore dramatically underinvesting in what is the core of the Italian economy – small companies.

The Made in Italy Fund concentrates only on small caps – companies with a market capitalization below one billion euro. They are 80% of the quoted names, but less than 10% of total market value.

The Fund’s objective is to select the best 30 companies within that universe, in terms of profitability, growth and valuation.

INVESTMENT PHILOSOPHY

Investment Philosophy

Markets are not efficient, but continually offer attractive opportunities to active investors who can take advantage of them through diligent analysis of intrinsic value.

Stocks are not bits of paper of a trading game, but represent a fractional ownership of a company, allowing investors to share in the company’s profits.

The Fund selects stocks with the mind-set of a long term investor, who wants to participate in the success of the companies he owns. Its aim is to be a stable shareholder and a point of reference for the best companies in the dynamic Italian Small cap universe.

SELECTION PROCESS

screening

Company screening

Constant search for attractive investment opportunities, through a systematic screening of the Small cap universe based on quantitative and qualitative rules, as well as through taking advantage of bargains offered by market volatility.

fund analysis

Fundamental analysis

Analyses are centred on a direct relationship with top management and regular visits to company headquarters. Selection is based on the history of financial reports and valuation, with emphasis on corporate governance and share ownership.

valuation

Valuation

The aim of the valuation work is to estimate the company’s profitability and growth prospects in order to arrive at a reasonable assessment of its intrinsic value.

process part 1
selection

Selection decision

The Fund selects companies where there is a considerable gap between intrinsic value and market price. The magnitude of such margin of safety determines the size of the position.

monitoring

Selection monitoring

Once in the portfolio, companies are constantly monitored to ensure the validity of the selection thesis. Position weights are adjusted accordingly.

decision

Deselection decision

The Fund has a low turnover. Positions exit the portfolio once they close their value gap through appreciation, or in order to leave space to more attractive alternatives.

process part 2

RISKS

The Fund is invested in small stocks, many of which have limited free float and daily liquidity. Therefore, it can be subjected to periods of heightened volatility and may be adversely affected by periods of extensive and prolonged equity market downturns.

Risk

You do not adhere to its long term orientation and intend to trade in and out of the Fund for short periods of time.

You are a highly risk-averse investor, unprepared to bear the Fund’s volatility.

You intend to invest in the Fund more than a limited portion of your overall financial wealth.

MASSIMO FUGGETTA

Bayes Investments Founder and CIO

Massimo started his career as a portfolio manager in 1988 at JP Morgan Investment Management in London, where he rose to become Head of the Global Balanced Group, with overall responsibility for international balanced portfolios. In 1999 he left JPMIM to become Chief Investment Officer and Director General at Sanpaolo IMI Asset Management in Milan, where in 2000 he became Chief Executive Officer. He left the company in 2001 to start Horatius, which was incorporated in 2004 as an advisory company and in 2007 became an asset management company. He was a founding shareholder, a Board member and the CIO of Horatius. In 2012 Massimo left Horatius and went back to London, where in 2014 he founded Bayes Investments.

Massimo graduated in Economics at LUISS, Rome and holds a Master’s Degree (M.Phil.) and a Doctorate (D.Phil.) in Economics from the University of Oxford (Trinity College). Massimo also taught Behavioural Finance in the Master in Economics course at Bocconi University in Milan and served in the Editorial Board of the Financial Analyst Journal.

In 2012, Massimo started the Bayes blog at www.massimofuggetta.com, which has acquired popularity in the Value Investing community.

Massimo Fuggetta

BOARD OF DIRECTORS

Massimo Fuggetta, Chairman

Guido Manca
is the Chief Executive Officer at Independent Strategy Ltd. in London. He runs the company and looks after global marketing and distribution of the firm’s products. He started his career at Salomon Brothers (fixed income) followed by Morgan Stanley (equities). He co-founded Independent Strategy in 1994. He holds an Honours degree in Economics from Trinity College, Cambridge.

Alexandros Rammos, Secretary
has 20 years experience in financial markets. In 1990, his family founded Pegasus Securities in Athens, a brokerage company which rose to prominence by eventually becoming one of the largest privately-owned retail brokerage houses in Greece. Alexandros was the company CEO between 2009 and 2011. In 2014 he became Managing Partner of Versal Investment Services, an independent investment advisor in Athens. He joined New College Capital in October 2015 mainly focusing on compliance and business development.

STRATEGIC ADVISORS

Alessandro Ciravegna
has 31 years experience in financial markets. He began his career at Merrill Lynch in London and subsequently joined Citigroup in various investment advisory and business management functions in London, Milan, Athens and New York. In 2002, he founded New College Capital Ltd to provide specialist investment advice to European investors.

Giulio Antonello
started working in New York in 1990 as an investment banker for Credit Agricole. In 1993, he joined Societé Suisse de Ciment Portland in Switzerland. Soon after, he was instrumental to the creation of the IBI Group, an advisory and merchant banking boutique with offices in Milan, Zurich and Lugano. From 1997 to 2005, he led several advisory and investment projects. In 2006 he became CEO of Alerion, with the objective of focusing the company on the renewable energy sector. He left Alerion in 2015 and currently operates as an independent investor. His family holding company, Financière Phone 1690, has stakes in a number of listed and private companies in the real estate, industrial, energy and agricultural sectors.

Blog

Three proposals to relaunch PIRs

With the Decree of 30 April 2019, the Italian government confirmed the changes made earlier this year to the law on Individual Savings Plans (Piani Individuali di Risparmio, PIR) introduced in 2017. The decree specifies that PIRs opened from 2019 onwards must be invested for at least 3.5% in companies listed on AIM and for […]

Why so few?

It is known in finance as the equity home bias puzzle: investors’ preference for domestic equities and their consequent portfolio overweight compared to the precepts of standard theory. Not in Italy. While laden with domestic government bonds, Italian investors have no penchant for domestic equities. They don’t think of equities as domestic vs. foreign: Italian […]

DISCLAIMER

 

Bayes Investments Ltd is registered in England and Wales, with registered number 09325205, registered office: 39-40 St. James’s Place, London SW1A 1NS, United Kingdom. Bayes Investments Ltd is an Appointed Representative of New College Capital Ltd. New College Capital Ltd (FRN 430986) is authorised and regulated by the UK Financial Conduct Authority (FCA).

 

The following information is for your own protection and benefit. It explains certain legal and regulatory restrictions, which apply to any investment in the products referred to in this website. After you have read and understood the following information, please click the ‘I AGREE’ button below to acknowledge that you have read and understood the information.

 

By accessing, browsing, and/or using this Website or linked websites and any pages hereof, you are indicating that you have read, acknowledged and agreed to be bound by this Terms and Conditions.

 

This website uses cookies to store information on your computer. By accessing this site, you consent to the placement of cookies on your machine as described in the Cookie Policy (https://www.iubenda.com/privacy-policy/7899816/cookie-policy). If you do not consent to the use of cookies, please either disable cookies or refrain from accessing this site or any pages thereof.

 

By accepting these Terms and Conditions, you agree to the processing and disclosure of personal information as described in our Privacy Policy (https://www.iubenda.com/privacy-policy/7899816).

 

TERMS AND CONDITIONS

 

We may change these Terms from time to time, at any time without notice to you, by posting such changes on the website. BY USING THE WEBSITE, YOU ACCEPT AND AGREE TO THESE TERMS, AS THEY MAY FROM TIME TO TIME BE REVISED, AS APPLIED TO YOUR USE OF THE WEBSITE. If you do not agree to these Terms, you may not access or otherwise use the website.

 

The information contained on the pages of this website should not be considered as an offer, or solicitation, to deal in any of the investments or funds mentioned herein, by anyone in any jurisdiction in which such offer or solicitation would be unlawful or in which the person making such offer or solicitation is not qualified to do so or to anyone to whom it is unlawful to make such offer or solicitation.

 

Reference to companies or other investments mentioned within this website should not be construed as a recommendation to the investor to buy or sell the same, but is included for the purpose of illustration.

 

This website is intended only for use by Professional Investors resident in the United Kingdom and is directed exclusively at persons who are professional clients or eligible counterparties for the purposes of the FCA handbook of rules and guidance. The information contained in this website must not be used or relied upon by retail investors. This website may contain information or documents which constitute a financial promotion for the purposes of the Financial Services and Markets Act 2000 and the FCA Rules.

 

The fund to which this website relates is only available to the persons referred to above and other persons should not act or rely on the information contained on this website. This website is not intended to constitute, and should not be construed as, investment advice. Potential investors should seek their own independent financial advice.

 

The information contained within this website is not aimed at persons who are residents of any country where the funds referred to herein are not registered or approved for marketing and/or sale or in which the dissemination of information on the funds or services is not permitted. Any persons who are not resident in the UK and who access this website are required to inform themselves of and to comply with any applicable jurisdictional restriction.

 

Our website is not intended for persons in the US, as the products contained in this website are not available for distribution to or investment by US investors. The funds are not registered under the United States Securities Act of 1933 or the United States Investment Company Act of 1940.

 

The information contained within this website is published in good faith but no representation or warranty, expressed or implied is made by Bayes Investments Ltd as to its accuracy or completeness and no information on this website constitutes investment, tax, legal or other advice. We use all reasonable efforts to ensure that the information contained on this website is current and accurate as at the date of publication. However, we can give no warranties, whether express or implied, as to the reliability, accuracy or completeness of the information.

 

No liability is assumed for any use of the information available on this website.

 

We take all reasonable steps to ensure the security of the website and your personal information, and to comply with all relevant laws and regulations. We are not responsible for the site’s accessibility nor availability.

 

All intellectual property rights on this site are owned by Bayes Investments Ltd. and may not be reproduced or copied.

 

You are only permitted to use this website and the services available through it for your own personal, non-commercial purposes. You may download or print individual sections of the site for personal use and information only provided you retain all copyright and other proprietary notices. You may not reproduce (in whole or in part), transmit (by electronic means or otherwise), modify, link into or use for any public or commercial purpose the site without our prior written consent. You are responsible for the computer equipment and software used to access this website and for all costs incurred in accessing and using this website.

 

Any attempt to damage this website may be illegal and we reserve the right to seek damages from any such perpetrator; this includes but is not limited to placing abusive, illegal, offensive information; information that contains a virus o have harmful content, information that can interfere with the operation or content of this website.

 

This website may contain articles, advice or statements from third parties. We make no representation as to the accuracy, completeness, timeliness, or suitability of such information that will not be updated. We are not responsible for any information or services available through links to third parties. Any use made of such information is at your own risk. Some of the information contained on this website may also have been prepared or provided by third parties and may not have been verified by us. We hereby exclude any liability arising out of any preparation or provision of such information for this website and make no warranty as to the accuracy, suitability or completeness of any such information.

 

Prospective investors should always consult an independent professional advisor for advice on these matters. Any investment made in the funds described herein is made on the basis of the information and risk disclosures contained in each of the fund’s respective Prospectus and Key Investor Information Document. This information is available on www.atomosicav.com.

 

Past performance is not an indicator of future results. The capital and the income of any investment is at risk can fall as well as rise; the investor may not get back the amount originally invested. Past performance is no guarantee of future returns.

 

The use of this website is governed by the law of England and Wales and you agree to submit to the exclusive jurisdiction of the English courts.

 

If any term or provision of these terms and conditions shall be unlawful, void or for any reason unenforceable, then that provision shall be deemed severable and shall not affect the validity and enforceability of the remaining terms or provisions, but such term or provision will be deemed modified to the extent necessary to render such term or provision enforceable.

 

I HAVE READ, ACKNOWLEDGED AND AGREED TO BE BOUND BY THE TERMS AND CONDITIONS.

 

I CONFIRM THAT I AM A PROFESSIONAL INVESTOR/ELIGIBLE COUNTERPART*

 

I CONFIRM THAT I AM NOT A US RESIDENT ** AND I WISH TO PROCEED.

 

* https://www.handbook.fca.org.uk/handbook/COBS/3/5.html

 

** As defined in the Regulation S under the United States Securities Act of 1933

 

I AGREE     DO NOT AGREE